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Kathryn B. Garber1,*Evaluation of a Newborn-Screening Protocol
for Preemies
Among premature babies, low birth weights, immature
livers, and the use of total parenteral nutrition (TPN) can
increase the likelihood that they will fail the newborn
screen. Rather than brush these babies off as false positives,
it is important to keep in mind that babies in the neonatal
intensive care unit (NICU) are more likely to have a true
metabolic disorder. Various amendments to newborn-
screening protocols have been recommended for preemies
such that truly affected babies can be found but that
the number of false-positive screens can be kept to a
minimum. Morris et al. assessed one such amendment in
a sample of NICU babies and found that it reduces the
false-positive rate by almost four times. In their strategy,
TPN was replaced with 10% dextrose in water for 3 hr prior
to a heel stick for the newborn screen. The number of
false positives was substantially lower than that from the
year before the protocol was initiated and in turn reduced
the estimated cost of follow-up testing in the population
by 80%.
Morris et al. (2013). Genet. Med. Published online October
31, 2013. http://dx.doi.org/10.1038/gim.2013.171.
Mutations in the Paternal Copy of MAGEL2
in Autism Patients
Prader-Willi and Angelman syndromes are due to loss of
expression of opposite alleles within an imprinted region
on chromosome 15. Although Angelman syndrome boils
down to a loss of function of one gene (UBE3A), it is gener-
ally thought that Prader-Willi syndrome is a contiguous
gene syndrome. However, this might not be the cause
in all cases; Schaaf et al. recently identified mutations in
MAGEL2, another gene in this region, in four patients
with autism and a Prader-Willi-syndrome-like phenotype.
After the first MAGEL2 mutation was uncovered via
whole-genome sequencing of an adolescent boy with
features of Prader-Willi syndrome, the database of whole-
exome sequences at Baylor College of Medicine was
searched for other possible mutations in the gene. Three
additional boys with autism had nonsense or frameshift
mutations in this gene, and further analysis indicated
that all four mutations were on the paternal allele.
Although MAGEL2 mutations have not been reported in
other exome studies of autism patients, this set of patients
suggests that it is a candidate gene for further analysis in1Department of Human Genetics, Emory University School of Medicine, Atlan
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The Americanindividuals with autism, particularly in the context of
features of Prader-Willi syndrome.
Schaaf et al. (2013). Nat. Genet. 45, 1405–1408.
Young Women with Breast Cancer and Their Decision
to Have Prophylactic Mastectomy
Concerned by rising rates of contralateral prophylactic
mastectomy in women with early-stage breast cancer
despite the uncertainty of its benefit, Rosenberg et al.
explored the decision-making process and risk perception
in women who made this choice. Their sample included
more than 100 women (with and without BRCA1 and
BRCA2 mutations) who were diagnosed with breast
cancer at age 40 or younger and who chose to have the
contralateral breast removed. Although the majority of
them felt that they had made the right decision to have
both breasts removed, the procedure took a higher phys-
ical and psychological toll than what many of them had
expected. Despite understanding that the contralateral
mastectomy would not improve their survival, nearly
80% of these women cited the desire to improve their
survival as extremely important in their decision-making
process. These survey results could inform the develop-
ment of tools to assist other breast-cancer-affected women
who are making similar decisions.
Rosenberg et al. (2013). Ann. Intern. Med. 159, 373–381.
Third-Generation Tyrosine Kinase Inhibitor
of BCR-ABL
Gleevec was a revolutionary treatment not only for its
success in treating chronic myelogenous leukemia
(CML) but also because it was one of the first cancer drugs
that specifically targeted a driver mutation in cancer: the
BCR-ABL fusion gene created by the Philadelphia chro-
mosome translocation. Because cancers are genetically
unstable, resistance to Gleevec can develop, often via a
p.Thr315Ile substitution in BCR-ABL. What then? The
results of a phase 2 trial of ponatinib, a third-generation
tyrosine kinase inhibitor that also targets BCR-ABL,
suggest that many patients with CML or Philadelphia-
chromosome-positive acute lymphoblastic leukemia will
respond to this new drug. Despite having received other
tyrosine kinase inhibitors before ponatinib, around
40%–50% of patients in most clinical subgroups had a
major cytogenetic response. Unfortunately, thrombotic
events occurred in some patients receiving the drug, andta, GA 30322, USA
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trials of ponatinib are on hold despite its efficacy in these
patients.
Cortes et al. (2013). N. Engl. J. Med. 369, 1783–1796.
Mitotic Chromosome Organization
The condensed ‘‘X’’ of mitotic chromosomes is the classic
shape in which our genetic material is depicted. However,
exactly how the double helix of DNA forms this compact
structure is less clear. Using two different methods to
capture chromosome conformation, Naumova et al.
showed that the metaphase chromosomes in a variety of998 The American Journal of Human Genetics 93, 997–998, Decembcell types adopt a similar three-dimensional folding state
that is quite distinct from the folding states observed in
interphase cells. The model that best fits their data is one
in which loops of DNA form locally and independently
of sequence and then are linearly compressed. Because
this organization seems to be used in a range of cell types,
higher-order chromatin structures specific to certain cell
types probably do not comprise epigenetic information
because the structures must reform which each cell cycle.
Naumova et al. (2013). Science. Published online November
7, 2013. http://dx.doi.org/10.1126/science.1230683.This Month in Our Sister JournalsA Genetic Hub for Coronary Heart Disease
Typical genome-wide association studies look for loci that
influence a single trait. Because many genes work in path-
ways, this greatly simplifies complex systems into a trac-
table problem; however, it does not allow for gene-gene or
gene-environment interactions. Interested in coronary
heart disease, a complex trait for which there is significant
missing heritability, Maxwell et al. wanted to explore the
role of gene-gene interactions in this disease. They sought
loci that showed significant interaction with APOE, a genethat is well known to influence risk of heart disease. Their
process made use of the idea that APOE is a relationship
locus, one that influences the correlation between other
traits (in this case, total cholesterol and triglyceride levels).
Their genome scan yielded loci that influence the risk
relationship between these lipid levels and heart disease
and that have not been identified previously in typical ap-
proaches to genetic association for coronary heart disease.
Maxwell et al. (2013). Genetics. Published online October 4,
2013. http://dx.doi.org/10.1534/genetics.113.157719.er 5, 2013
